Gangrene and renal failure caused by dihydroergotamine used to treat raised intracranial pressure following head trauma.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 8721476.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A case of peripheral gangrene and renal failure following the use of dihydroergotamine (DHE) for treatment of raised intracranial pressure (ICP) is reported. There have been several reports of vasospasm and peripheral gangrene caused by DHE used in combination with heparin for prevention of deep venous thrombosis. Clinical experience with the use of DHE in head trauma is limited. This case report emphasises the seriousness of the adverse effects associated with the use of this drug.
Medical subject headings
- Craniocerebral Trauma
- Dihydroergotamine
- Gangrene
- Pseudotumor Cerebri
- Renal Insufficiency
- Vasoconstrictor Agents